Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Biomed Nanotechnol ; 12(4): 717-31, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27301198

RESUMO

The tranquillizing effects of quercetin on allergic asthma are promising, but its poor water solubility and bioavailability is still a bottleneck. In this study, an ovalbumin (OVA) sensitized BALB/c mice asthma model was used to investigate the potential of quercetin nanocrystals (nQ) on relieving asthma aggravation. The water soluble nQ was prepared by the homogenization using the high energy sonication method. X-ray diffraction data showed the formation of nQ (10-30 nm) which was in agreement with transmission electron microscopy. The nQ was found to be more stable and soluble in PBS, and sera of BALB/c mice compared to bulk quercetin. Dose dependent experiments with nQ on OVA sensitized asthma mice exhibited significant anti-asthmatic potential of nQ at much lower dose (1 mg/kg body weight) compared to bulk quercetin. The treatment of nQ remarkably resulted in reduced OVA specific immunoglobulin E (sIgE) production, anaphylaxis signs and type 1 skin test. The nQ also significantly modulated the expression of Th2 cytokines like IL-4 and IL-5, which are responsible for IgE class switching and suppressed the degranulation/secretion of different chemical mediators (PGD2, mMCPT-1 Cys-L and TSLP) from activated mast cells. The levels of FcεR1, Syk, c-Yes, PI-3, p-PI-3, PLC-γ2, and p-PLC-γ2 were found to be reduced in the OVA sensitized BALB/c mice treated with nQ compared to those treated with OVA only. The results indicate that nQ alleviate pulmonary inflammation and airway hyporesponsiveness in allergic asthma at much lower dose compared to bulk quercetin and may be considered as a potential drug for the treatment of asthmatic patients.


Assuntos
Asma/tratamento farmacológico , Asma/imunologia , Mastócitos/imunologia , Nanocápsulas/química , Quercetina/administração & dosagem , Transdução de Sinais/imunologia , Animais , Antiasmáticos/administração & dosagem , Antiasmáticos/química , Antioxidantes/administração & dosagem , Antioxidantes/química , Asma/patologia , Citocinas/imunologia , Relação Dose-Resposta a Droga , Sinergismo Farmacológico , Feminino , Mastócitos/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos BALB C , Nanocápsulas/administração & dosagem , Nanocápsulas/ultraestrutura , Quercetina/química , Indução de Remissão/métodos , Transdução de Sinais/efeitos dos fármacos , Resultado do Tratamento
2.
J Nanosci Nanotechnol ; 12(9): 7105-12, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23035440

RESUMO

The antimicrobial activities of zirconia (ZrO2) nanoparticles and zirconium mixed ligand complexes were studied on bacterial strains of E. coli, S. aureus and fungal strain of A. niger. The nanoparticles of zirconia and Zr(IV) complexes with different amino acids as ligands were synthesized by hydrothermal method. X-ray diffraction (XRD) and HRTEM confirmed the crystalline nature and morphology of the synthesized products. The antimicrobial studies revealed that the zirconia exhibits activity only against the E. coli, whereas, the Zr(IV) complexes exhibits activity against both the bacteria: gram -ve E. coli and gram +ve S. aureus as well as fungal strains. The Zr(IV) complexes are found to possess significant antifungal activity against A. niger. The results are indicative of crystal plane-dependent antimicrobial activity of zirconia nanoparticles and complexes. The observed difference in the antibacterial activity of ZrO2 crystals and Zr(IV) complexes may be ascribed to the atomic arrangements of different exposed surfaces. On the basis of the study, it could be speculated that the ZrO2 nanoparticles with the same surface areas but with different shapes i.e., different active facets will show different antimicrobial activity.


Assuntos
Antibacterianos/farmacologia , Nanopartículas , Zircônio/farmacologia , Aspergillus niger/efeitos dos fármacos , Escherichia coli/efeitos dos fármacos , Microscopia Eletrônica de Transmissão , Difração de Raios X
3.
J Helminthol ; 72(3): 243-9, 1998 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-9765377

RESUMO

The structure of the digestive tract of Euclinostomum multicaecum (Digenea: Euclinostomatidae) is unusual, comprising several main lateral caeca which extend posteriorly and further divide, giving rise to numerous smaller branches which are widely distributed throughout the fluke. These multicaeca presumably promote nutrient absorption during rapid and prolonged feeding directly following excystment. The caecal wall consists of a syncytial gastrodermal epithelium, bearing loop-like lamellae which extend into the lumen and enclose spherical inclusion bodies and presumably also, increase the absorptive surface area. There was no evidence of endo- or exocytosis, nor were lysosomes, phagosomes or residual bodies observed. The gut caeca are supported by a fibrous basal lamina and an underlying layer of muscle fibres, while parenchymal cells occupy much of the extracellular space. The protonephridial system resembles that observed in other digeneans consisting of flame cells and collecting ducts which join to form a bladder that opens externally through a single excretory pore. The syncytial epithelium of the collecting ducts is elevated by numerous lamellae while the basal lamina is highly infolded. The luminal contents of these ducts comprise bar-shaped crystalline structures, lipid droplets and electron-dense inclusion bodies. The excretory system is supported by a network of muscle fibres and parenchymal cells.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...